Question 1

All the following are true about RhIg except

Accepted Answer

A) Can be used in some cases as an alternative to IVIG 
B) Contributes to fluid balance both within the blood vessels and throughout the body 
C) Is administered to prevent immunization to the D antigen 
D) Is often administered intramuscularly when given in the perinatal or postnatal period 
A) Can be used in some cases as an alternative to IVIG 
B) Contributes to fluid balance both within the blood vessels and throughout the body 
C) Is administered to prevent immunization to the D antigen 
D) Is often administered intramuscularly when given in the perinatal or postnatal period B

Question 2

Whole blood transfusion achieves all of the following except

Accepted Answer

A) Improved cellular immune function 
B) Improved tissue oxygenation 
C) Replacement of fluid 
D) Replacement of nonlabile coagulation factors 
A) Improved cellular immune function 
B) Improved tissue oxygenation 
C) Replacement of fluid 
D) Replacement of nonlabile coagulation factors A

Question 3

A platelet count of less than _____ is often used as a trigger to initiate prophylactic platelet transfusions to prevent intracranial hemorrhage.

Accepted Answer

A) 10 × 10³ / µL (10 x 10⁹/L) 
B) 20 × 10³ / µL (20 x 10⁹/L) 
C) 30 × 10³ / µL (30 x 10⁹/L) 
D) 40 × 10³ / µL (40 x 10⁹/L) 
A) 10 × 10³ / µL (10 x 10⁹/L) 
B) 20 × 10³ / µL (20 x 10⁹/L) 
C) 30 × 10³ / µL (30 x 10⁹/L) 
D) 40 × 10³ / µL (40 x 10⁹/L) A

Question 4

Which statement is true regarding granulocyte transfusion?

Accepted Answer

A) Is used primarily as interim therapy for patients who expect to recover neutrophil production. 
B) Is first-line therapy for patients with bacterial or fungal sepsis. 
C) May be acceptable to some patients who refuse other blood transfusions for religious reasons. 
D) May use an autologous blood component. 
A) Is used primarily as interim therapy for patients who expect to recover neutrophil production. 
B) Is first-line therapy for patients with bacterial or fungal sepsis. 
C) May be acceptable to some patients who refuse other blood transfusions for religious reasons. 
D) May use an autologous blood component.

Question 5

What gauge of needle is typically used for blood transfusions?

Accepted Answer

A) 18 
B) 21 
C) 23 
D) 25 
A) 18 
B) 21 
C) 23 
D) 25

Question 6

Which of the following is not a benefit to using fresh frozen plasma?

Accepted Answer

A) Helps prevent bleeding due to coagulopathy 
B) Improves hemostasis 
C) Provides all coagulation factors 
D) Provides functional platelets 
A) Helps prevent bleeding due to coagulopathy 
B) Improves hemostasis 
C) Provides all coagulation factors 
D) Provides functional platelets

Question 7

Cryoprecipitate contains which coagulation factors?

Accepted Answer

A) Factor V,factor VII,factor VIII 
B) Factor VII,factor VIII,factor XIII 
C) Fibrinogen,factor V,factor VIII 
D) Fibrinogen,factor VIII,factor XIII 
A) Factor V,factor VII,factor VIII 
B) Factor VII,factor VIII,factor XIII 
C) Fibrinogen,factor V,factor VIII 
D) Fibrinogen,factor VIII,factor XIII

Question 8

Where do the majority of hematopoietic progenitor cells (HPCs)reside?

Accepted Answer

A) bone marrow 
B) lymphatic system 
C) peripheral circulation 
D) striated muscle 
A) bone marrow 
B) lymphatic system 
C) peripheral circulation 
D) striated muscle

Question 9

Which of the following is most commonly used as a volume replacement in trauma,shock,burns,and therapeutic plasma exchange?

Accepted Answer

A) Albumin 
B) Fibrinogen 
C) Globulin 
D) Lipoprotein 
A) Albumin 
B) Fibrinogen 
C) Globulin 
D) Lipoprotein

Question 10

Which of the following is the first treatment step in responding to massive blood loss?

Accepted Answer

A) Establish an intravenous access 
B) Infuse colloid solutions 
C) Improve oxygen delivery 
D) Restore circulating systemic volume 
A) Establish an intravenous access 
B) Infuse colloid solutions 
C) Improve oxygen delivery 
D) Restore circulating systemic volume

Question 11

All of the following statements are true of intraoperative blood salvage except

Accepted Answer

A) Bacteria at the site of the surgery are washed out of the blood before reinfusion. 
B) Blood can be collected during or after surgery. 
C) Collected blood can be reinfused as either whole blood or red blood cells. 
D) Collected blood is mixed with anticoagulant. 
A) Bacteria at the site of the surgery are washed out of the blood before reinfusion. 
B) Blood can be collected during or after surgery. 
C) Collected blood can be reinfused as either whole blood or red blood cells. 
D) Collected blood is mixed with anticoagulant.

Question 12

Patients rarely need red blood cell transfusions if the hemoglobin concentration is

Accepted Answer

A) Below 7 g/dL (70 g/L)and the patient has a low oxygen saturation level 
B) Below 10 g/dL (100 g/L)and the patient is bleeding 
C) Between 7 and 10 g/dL (70 and 100 g/L)and the patient has underlying cardiac disease 
D) Above 10 g/dL (100 g/L)and the patient is hemodynamically stable 
A) Below 7 g/dL (70 g/L)and the patient has a low oxygen saturation level 
B) Below 10 g/dL (100 g/L)and the patient is bleeding 
C) Between 7 and 10 g/dL (70 and 100 g/L)and the patient has underlying cardiac disease 
D) Above 10 g/dL (100 g/L)and the patient is hemodynamically stable

Question 13

The infusions of all blood components should occur in less than ___ hours.

Accepted Answer

A) 2 
B) 3 
C) 4 
D) 5 
A) 2 
B) 3 
C) 4 
D) 5

Question 14

Which of the following is used as a presurgical prophylaxis to reduce or prevent bleeding in patients with mild hemophilia A?

Accepted Answer

A) Desmopressin 
B) G-CSF 
C) Vitamin K 
D) Recombinant EPO 
A) Desmopressin 
B) G-CSF 
C) Vitamin K 
D) Recombinant EPO

Question 15

Which of the following do hematopoietic progenitor cell (HPC)donors routinely receive prior to donation?

Accepted Answer

A) Desmopressin 
B) G-CSF 
C) Recombinant EPO 
D) Recombinant TPO 
A) Desmopressin 
B) G-CSF 
C) Recombinant EPO 
D) Recombinant TPO

Question 16

Autologous hematopoietic progenitor cells (HPCs)are collected from the patient's bone marrow or peripheral blood after

Accepted Answer

A) High doses of chemotherapy 
B) Low doses of chemotherapy 
C) High doses of 10% DMSO 
D) Low doses of 10% DMSO 
A) High doses of chemotherapy 
B) Low doses of chemotherapy 
C) High doses of 10% DMSO 
D) Low doses of 10% DMSO

Question 17

Which method might be used to decrease the risk of transfusion-associated cytomegalovirus (CMV)transmission?

Accepted Answer

A) Freezing 
B) Irradiation 
C) Leukoreduction 
D) Washing 
A) Freezing 
B) Irradiation 
C) Leukoreduction 
D) Washing

Question 18

Which of the following can be used to stimulate platelet production in patients suffering from bone marrow suppression that has caused thrombocytopenia?

Accepted Answer

A) G-CSF 
B) GM-CSF 
C) Recombinant EPO 
D) Recombinant TPO 
A) G-CSF 
B) GM-CSF 
C) Recombinant EPO 
D) Recombinant TPO

Question 19

Which of the following modifications can help to prevent the formation of antibodies to HLA antigens?

Accepted Answer

A) Freezing 
B) Irradiation 
C) Leukoreduction 
D) Washing 
A) Freezing 
B) Irradiation 
C) Leukoreduction 
D) Washing

Question 20

Community-directed donation programs are often used to find donors for patients suffering from one of which two diseases?

Accepted Answer

A) Anemia or coagulopathy 
B) Hemophilia A or hemophilia B 
C) Leukemia or lymphoma 
D) Sickle cell anemia or thalassemia 
A) Anemia or coagulopathy 
B) Hemophilia A or hemophilia B 
C) Leukemia or lymphoma 
D) Sickle cell anemia or thalassemia

Exam 11: Component Therapy and Massive Transfusion

All the following are true about RhIg except

Whole blood transfusion achieves all of the following except

A platelet count of less than _____ is often used as a trigger to initiate prophylactic platelet transfusions to prevent intracranial hemorrhage.

Which statement is true regarding granulocyte transfusion?

What gauge of needle is typically used for blood transfusions?

Which of the following is not a benefit to using fresh frozen plasma?

Cryoprecipitate contains which coagulation factors?

Where do the majority of hematopoietic progenitor cells (HPCs)reside?

Which of the following is most commonly used as a volume replacement in trauma,shock,burns,and therapeutic plasma exchange?

Which of the following is the first treatment step in responding to massive blood loss?

All of the following statements are true of intraoperative blood salvage except

Patients rarely need red blood cell transfusions if the hemoglobin concentration is

The infusions of all blood components should occur in less than ___ hours.

Which of the following is used as a presurgical prophylaxis to reduce or prevent bleeding in patients with mild hemophilia A?

Which of the following do hematopoietic progenitor cell (HPC)donors routinely receive prior to donation?

Autologous hematopoietic progenitor cells (HPCs)are collected from the patient's bone marrow or peripheral blood after

Which method might be used to decrease the risk of transfusion-associated cytomegalovirus (CMV)transmission?

Which of the following can be used to stimulate platelet production in patients suffering from bone marrow suppression that has caused thrombocytopenia?

Which of the following modifications can help to prevent the formation of antibodies to HLA antigens?

Community-directed donation programs are often used to find donors for patients suffering from one of which two diseases?

The Immune Process: the Origin and Interaction Between Antigens and Antibodies

Immunogenetics: the Origin of Antigens

Blood Bank Applications of Antigenantibody Reactions

Abo and Hh Blood Group Systems

Rh, Rhag, and Lw Blood Group Systems

Other Blood Group Systems

Pretransfusion and Compatibility Testing

Identification of Unexpected Antibodies

Donor Selection, Phlebotomy, and Required Testing

Blood Products: Preparation, Storage, and Shipment of Blood Components

Adverse Reactions to Transfusion

Transfusion-Transmitted Infections

Perinatal and Neonatal Transfusion Issues

Autoimmune and Drug-Induced Immune Hemolytic Anemias

Platelet Refractory Patients

Transfusion Support of Selected Patient Populations

Human Histocompatibility

Methods in Parentage Testing

Transfusion Safety and Regulatory Issues

Quality Assurance

Filters